Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hjm van Kan"'
Autor:
Roos S G Sablerolles, MD, Melvin Lafeber, MD, Janneke A L van Kempen, MD, Bob P A van de Loo, Msc, Eric Boersma, ProfPhD, Wim J R Rietdijk, PhD, Harmke A Polinder-Bos, MD, Simon P Mooijaart, MD, Hugo van der Kuy, ProfPharmD, Jorie Versmissen, MD, Miriam C Faes, MD, LA Agnoletto, J Aleman, S Andreassi, LM Andrews, L Ashfield, H Bell, AKB Bengaard, SB Berlinghini, KB Bini, ZB Bisoffi, KB Blum, E Boemaars, GB Boni, TM Bosch, BE Bosma, F Boutkourt, C Bufarini, A Bulsink, RC Cabuk, GC Callens, MC Candela, MC Canonici, EC Capone, IC Carmo, FC Caruso, PC Chessa, GC Cohet, I Cornelissen-Wesseling, KML Crommentuijn, FM de Stoppelaar, HAJM de Wit, DS Deben, LJJ Derijks, MDC Di Carlo, J Diepstraten, B Dilek, DMK Duchek-Mann, MM Ebbens, LJ Ellerbroek, M Ezinga, MF Falcao, FF Falcao, LF Fantini, HF Farinha, PMG Filius, NJ Fitzhugh, G Fleming, TF Forsthuber, GG Gambarelli, MG Gambera, CGY García Yubero, Z Getrouw, CN Ghazarian, N Goodfellow, MQG Gorgas, RG Grinta, K Guda, DH Haider, J Hanley, KH Heitzeneder, WL Hemminga, LC Hendriksen, DL Hilarius, FEF Hogenhuis, IC Hoogendoorn-de Graaf, MBH Houlind, MAH Huebler, KPGM Hurkens, PKC Janssen, E Jong, MHW Kappers, KFM Keijzers, MK Kemogni, EM Kemper, RA Kranenburg, LL Krens, JL G Le Grand, J Liang, S Lim, NL Lindner, EL Loche, AL Lubich, B Maat, CM Maesano, AM Maiworm, M Maragna, FM Marchesini, IM Martignoni, G M Martini, CM Masini, R Mc Menamin, DM Mendes, M Miarons, R Moorlag, MR Müller, FN Nagele, KN Nemec, GO Oka, AG Otten-Helmers, SP Pagliarino, FP Pappalardo, M Patel, PM Peverini, FP Pieraccini, EMP Platania, NPK Pons-Kerjean, LPH Portillo Horcajada, GR Rametta, JR Rijo, EE Roelofsen, E Roobol-Meuwese, LR Rossi, SAH Russel, Z Safipour, FS Salaffi, L Saleh, AMS Schimizzi, JMGA Schols, MS Schwap, MG Scott, EAM Slijfer, EMA Slob, JS Soares, MS Solano, F Sombogaard, GS Stemer, MT Tardella, PGJ ter Horst, RT Tessari, J Tournoy, RB van den Berg, L Van der Linden, PD van der Linden, SC van Dijk, RW Van Etten, IMM van Haelst, M van Heuckelum, HJM van Kan, C van Nieuwkoop, HAW van Onzenoort, P van Wijngaarden, JDJ Verdonk, Fv Verri, JAMC Verstijnen, MV Veyrier, EV Viegas, LE Visser, A Vos, MAM Vromen, PC Wierenga, DR Wong, CZ Zenico, TZ Zuppini
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
Summary: Background: During the COVID-19 pandemic, the scarcity of resources has necessitated triage of critical care for patients with the disease. In patients aged 65 years and older, triage decisions are regularly based on degree of frailty measur
Externí odkaz:
https://doaj.org/article/25542a489c0c438688fb4c4de1d44583
Autor:
Sah Russel, Jorie Versmissen, Wim J R Rietdijk, TZ Zuppini, AL Lubich, RB van den Berg, JL G Le Grand, FP Pieraccini, SP Pagliarino, J Liang, Jmga Schols, MK Kemogni, FN Nagele, SB Berlinghini, RC Cabuk, C van Nieuwkoop, R Mc Menamin, RG Grinta, Hjm van Kan, J Tournoy, MG Gambera, Dmk Duchek-Mann, J Hanley, Fef Hogenhuis, J Diepstraten, GC Cohet, B Maat, F Boutkourt, LA Agnoletto, Wong, Mdc Di Carlo, GS Stemer, JR Rijo, Miriam C Faes, DM Mendes, MV Veyrier, C Bufarini, J Aleman, Fv Verri, Michael G. Scott, Npk Pons-Kerjean, GR Rametta, F Sombogaard, FP Pappalardo, LR Rossi, LE Visser, FF Falcao, Kfm Keijzers, WL Hemminga, S Andreassi, RA Kranenburg, L Van der Linden, JS Soares, Mhw Kappers, N Goodfellow, MF Falcao, Hugo van der Kuy, GG Gambarelli, M Ezinga, MC Candela, L Ashfield, KH Heitzeneder, Harmke A Polinder-Bos, Melvin Lafeber, KB Blum, K Guda, CM Masini, EL Loche, Mqg Gorgas, LF Fantini, FM de Stoppelaar, NJ Fitzhugh, LM Andrews, Cgy García Yubero, Müller, Kml Crommentuijn, GC Callens, GB Boni, Jamc Verstijnen, Simon P. Mooijaart, Eric Boersma, H Bell, Ema Slob, KB Bini, DH Haider, R Moorlag, GO Oka, M Patel, CZ Zenico, Z Safipour, Glenda Fleming, Pmg Filius, IM Martignoni, PC Chessa, Hajm de Wit, DS Deben, Pgj ter Horst, Haw van Onzenoort, S Lim, Imm van Haelst, MC Canonici, EC Capone, IC Hoogendoorn-de Graaf, L Saleh, KN Nemec, TM Bosch, PM Peverini, TF Forsthuber, FM Marchesini, MM Ebbens, RT Tessari, PC Wierenga, NL Lindner, LJ Ellerbroek, A Bulsink, Ams Schimizzi, Roos S G Sablerolles, Kpgm Hurkens, BE Bosma, Pkc Janssen, Mah Huebler, FC Caruso, AM Maiworm, E Jong, Mam Vromen, RW Van Etten, M Miarons, EM Kemper, Akb Bengaard, Eam Slijfer, CN Ghazarian, PD van der Linden, Schwap, LL Krens, M van Heuckelum, CM Maesano, Ljj Derijks, MT Tardella, I Cornelissen-Wesseling, DL Hilarius, Jdj Verdonk, EV Viegas, IC Carmo, P van Wijngaarden, AG Otten-Helmers, ZB Bisoffi, G M Martini, Janneke A L van Kempen, SC van Dijk, LC Hendriksen, M Maragna, Emp Platania, E Roobol-Meuwese, B Dilek, E Boemaars, FS Salaffi, Lph Portillo Horcajada, HF Farinha, Z Getrouw, Bob P A van de Loo, A Vos, Mbh Houlind, EE Roelofsen, Solano
Publikováno v:
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd.
The Lancet. Healthy Longevity
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd
The Lancet Healthy Longevity, 2(3), e163-e170. Lancet Publishing Group
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
The Lancet Healthy Longevity
The Lancet Healthy Longevity, 2(3), E163-E170. ELSEVIER
The Lancet. Healthy Longevity
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd
The Lancet Healthy Longevity, 2(3), e163-e170. Lancet Publishing Group
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
The Lancet Healthy Longevity
The Lancet Healthy Longevity, 2(3), E163-E170. ELSEVIER
Background: During the COVID-19 pandemic, the scarcity of resources has necessitated triage of critical care for patients with the disease. In patients aged 65 years and older, triage decisions are regularly based on degree of frailty measured by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62769c4e206f6c565ea3d2e7353bb31f
https://pure.eur.nl/en/publications/63631910-99ae-4894-bf51-70737137322d
https://pure.eur.nl/en/publications/63631910-99ae-4894-bf51-70737137322d
Publikováno v:
Clinical pharmacology and therapeutics, 83(5), 718-722. Wiley-Blackwell
Patients with amyotrophic lateral sclerosis (ALS) who are treated with the antiglutamatergic drug riluzole receive a fixed-dose regimen of 50 mg b.i.d. The drug has been shown to increase tracheostomy-free survival by 3-6 months. The pharmacokinetics
Autor:
Geersing TH; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands., Franssen EJF; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands., Spronk PE; Department of Intensive Care Medicine, Gelre Hospitals Apeldoorn, Apeldoorn, The Netherlands., van Kan HJM; Department of Clinical Pharmacy, Gelre Hospitals Apeldoorn, Apeldoorn, The Netherlands., den Reijer M; Department of Clinical Microbiology & Infection Prevention, Gelre Hospitals Apeldoorn, Apeldoorn, The Netherlands., van der Voort PHJ; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; TIAS School for Business and Society, Tilburg University, Tilburg, The Netherlands.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Jul 28; Vol. 77 (8), pp. 2309-2311.
Autor:
Geersing TH; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands., Franssen EJF; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands., Spronk PE; Department of Intensive Care Medicine, Gelre Hospitals Apeldoorn, Apeldoorn, The Netherlands., van Kan HJM; Department of Clinical Pharmacy, Gelre Hospitals Apeldoorn, Apeldoorn, The Netherlands., den Reijer M; Department of Clinical Microbiology & Infection Prevention, Gelre Hospitals Apeldoorn, Apeldoorn, The Netherlands., van der Voort PHJ; Department of Critical Care, University Medical Center Groningen, University of Groningen, The Netherlands.; TIAS School for Business and Society, Tilburg University, Tilburg, The Netherlands.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Dec 24; Vol. 77 (1), pp. 246-252.
Autor:
Bakker T; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: t.bakker1@amsterdamumc.nl., Abu-Hanna A; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: a.abu-hanna@amsterdamumc.nl., Dongelmans DA; Amsterdam UMC (location AMC), Department of Intensive Care Medicine, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: d.a.dongelmans@amsterdamumc.nl., Vermeijden WJ; Department of Intensive Care, Medisch Spectrum Twente, Koningsplein 1, 7512, KZ, Enschede, the Netherlands. Electronic address: j.vermeijden@mst.nl., Bosman RJ; Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091, AC, Amsterdam, the Netherlands. Electronic address: r.j.bosman@olvg.nl., de Lange DW; Department of Intensive Care and Dutch Poison Information Center, University Medical Center Utrecht, University Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands. Electronic address: d.w.delange@umcutrecht.nl., Klopotowska JE; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: j.e.klopotowska@amsterdamumc.nl., de Keizer NF; Amsterdam UMC (location AMC), Department of Medical Informatics, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. Electronic address: n.f.keizer@amsterdamumc.nl., Hendriks S; Department of Intensive Care, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands., Ten Cate J; Department of Intensive Care, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schutte PF; Department of Intensive Care, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Balen D; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Duyvendak M; Department of Hospital Pharmacy, Antonius Hospital, Sneek, The Netherlands., Karakus A; Department of Intensive Care Diakonessenhuis Utrecht, Utrecht, The Netherlands., Sigtermans M; Department of Intensive Care Diakonessenhuis Utrecht, Utrecht, The Netherlands., Kuck EM; Department of Hospital Pharmacy, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Hunfeld NGM; Department of Intensive Care, Erasmus MC, Rotterdam, The Netherlands; Department of Hospital Pharmacy, ErasmusMC, Rotterdam, The Netherlands., van der Sijs H; Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., de Feiter PW; Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Wils EJ; Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Spronk PE; Department of Intensive Care Medicine, Gelre Hospitals, Apeldoorn, The Netherlands., van Kan HJM; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands., van der Steen MS; Department of Intensive Care, Ziekenhuis Gelderse Vallei, Ede, The Netherlands., Purmer IM; Department of Intensive Care, Haga Hospital, The Hague, The Netherlands., Bosma BE; Department of Hospital Pharmacy, Haga Hospital, The Hague, The Netherlands., Kieft H; Department of Intensive Care, Isala Hospital, Zwolle, The Netherlands., van Marum RJ; Department of Clinical Pharmacology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands; Amsterdam UMC (location VUmc), Department of Elderly Care Medicine, Amsterdam, The Netherlands., de Jonge E; Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands., Beishuizen A; Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands., Movig K; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands., Mulder F; Department of Pharmacology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Franssen EJF; OLVG Hospital, Department of Clinical Pharmacy, Amsterdam, The Netherlands., van den Bergh WM; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bult W; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hoeksema M; Zaans Medisch Centrum, Department of Anesthesiology, Intensive Care and Painmanagement, Zaandam, The Netherlands., Wesselink E; Department of Clinical Pharmacy, Zaans Medisch Centrum, Zaandam, The Netherlands.
Publikováno v:
Journal of critical care [J Crit Care] 2021 Apr; Vol. 62, pp. 124-130. Date of Electronic Publication: 2020 Dec 01.
Autor:
de Jong LAA; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands., Otten-Helmers AG; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands., Spronk PE; Department of Intensive Care, Gelre Hospitals, Apeldoorn, The Netherlands., van Kan HJM; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands.
Publikováno v:
Critical care medicine [Crit Care Med] 2019 Dec; Vol. 47 (12), pp. e984-e992.
Autor:
Ros JJW; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands., Koekkoek TJ; Department of Clinical Pharmacy, Rivierenland Hospital, Tiel, The Netherlands., Kalf A; Department of Clinical Geriatrics, Gelre Hospitals, Apeldoorn, The Netherlands., van den Bemt PMLA; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Van Kan HJM; Department of Clinical Pharmacy, Gelre Hospitals, Apeldoorn, The Netherlands.
Publikováno v:
European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2017 Jan; Vol. 24 (1), pp. 26-30.